Finance

Lists
AZTA:NASDAQ
Azenta, Inc
USD 34,28
+0,09%
(+0,030) 1D
USD 34,28
0,00% (0,00)
After hours
Closed: 29 Sep., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AZTA...
Open
USD 34,21
High
USD 34,45
Low
USD 33,66
Mkt. cap
1,50 mjd
Avg. vol.
839,10 k
Volume
779,79 k
52-wk high
USD 41,73
52-wk low
USD 15,93
EPS
-USD 2,66
Beta
1,40
Shares outstanding
43,81 m
No. of employees
3 k
Open
USD 34,21
High
USD 34,45
Low
USD 33,66
Mkt. cap
1,50 mjd
Avg. vol.
839,10 k
Volume
779,79 k
52-wk high
USD 41,73
52-wk low
USD 15,93
EPS
-USD 2,66
Beta
1,40
Shares outstanding
43,81 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Azenta, was founded in 1978, and is based in Burlington, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics. Wikipedia
About Azenta, Inc
CEOJohn Marotta
Employees2,9 k
Founded1978
HeadquartersBurlington, Massachusetts, Verenigde State van Amerika
SectorHealth care
Websiteazenta.com
Analyst ratings
Based on 3 analysts giving stock ratings to AZTA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AZTA in the last 3 months.
Highest
Current USD 34,28
USD 37,00 (+7,93%)
Average
USD 35,00 (+2,10%)
Lowest
USD 33,00 (-3,73%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Saxon
Needham
Buy
Maintained
USD 37,00
+7,9%
09/14/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
USD 35,00
+2,1%
08/06/2026
Brendan Smith
TD Cowen
Hold
Maintained
USD 33,00
-3,7%
08/05/2026
Matthew Stanton, CFA
Jefferies
Buy
Maintained
USD 35,00
+2,1%
04/01/2026
Last report
05 Aug. 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
USD 0,16 / USD 0,10
+60,00%beat
Revenue / Est. (USD)
161,18 m / 149,23 m
+8,00%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
158,95 m
148,64 m
144,80 m
161,18 m
Cost of goods sold
90,99 m
84,94 m
82,76 m
88,82 m
Cost of revenue
90,99 m
84,94 m
82,76 m
88,82 m
Research and development expenses
10,46 m
9,19 m
9,43 m
8,85 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,73 m
60,61 m
67,89 m
67,17 m
Operating expense
66,18 m
69,80 m
77,32 m
76,02 m
Total operating expenses
157,17 m
154,74 m
160,08 m
164,84 m
Operating income
1,78 m
-6,09 m
-15,28 m
-3,66 m
Other non operating income
2,18 m
979,00 k
801,00 k
1,30 m
EBT including unusual items
5,78 m
-2,06 m
-157,34 m
846,00 k
EBT excluding unusual items
8,28 m
-917,00 k
-10,70 m
1,36 m
Income tax expense
-45,61 m
3,13 m
-323,00 k
2,38 m
Effective tax rate
-789,61%
-151,94%
0,21%
280,73%
Other operating expenses
-
-
-
-
Net income
50,84 m
-15,43 m
-160,80 m
2,46 m
Net profit margin
31,98%
-10,38%
-111,05%
1,52%
Earnings per share
0,21
0,09
-0,04
0,16
Interest and investment income
5,02 m
5,10 m
4,39 m
3,82 m
Interest expense
-
-
-
-
Net interest expenses
5,02 m
5,10 m
4,39 m
3,82 m
Depreciation and amortization charges
-
-
-
-
EBITDA
16,29 m
7,55 m
-1,28 m
9,92 m
Gain or loss from assets sale
93,07 m
9,65 m
6,33 m
-5,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme